Evaluation of serum HER2 extracellular domain in in metastatic gastric or gastroesophageal junction cancer: Correlation with HER2 status by immunohistochemistry and fluorescence in situ hybridization and clinicopathologic parameters.
Xin An(Sun Yat-sen University), Yuhong Li(Southwest Jiaotong University), Fang Wang(First Affiliated Hospital of GuangXi Medical University), Yanan Kong(Sun Yat-sen University), Shuqin Dai(Sun Yat-sen University), Cong Li(Zhejiang Cancer Hospital), Feng‐Hua Wang(Sun Yat-sen University), Hui Luo(Sun Yat-sen University), Yongchang Chen(Jiangsu University), Rui‐Hua Xu(Sun Yat-sen University), Chen Cui(Sun Yat-sen University), Qiong Shao(Sun Yat-sen University), Ying Liang(Nanjing Agricultural University)
Cited by 2
Related Papers
Circular RNA: metabolism, functions and interactions with proteins
|Molecular Cancer|2020|1.6k
Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction
|Journal of Clinical Oncology|2016|1k
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
|New England Journal of Medicine|2019|934
METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma
|Molecular Cancer|2019|868